ACUTE LYMPHOBLASTIC LEUKEMIA IN REMISSION
Clinical trials for ACUTE LYMPHOBLASTIC LEUKEMIA IN REMISSION explained in plain language.
Never miss a new study
Get alerted when new ACUTE LYMPHOBLASTIC LEUKEMIA IN REMISSION trials appear
Sign up with your email to follow new studies for ACUTE LYMPHOBLASTIC LEUKEMIA IN REMISSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New vaccine could shield transplant patients from deadly virus
⭐️ VACCINE ⭐️ OngoingThis study tests a vaccine designed to protect people who have had a stem cell transplant from a common virus called CMV. The virus can cause serious illness in those with weak immune systems. The vaccine uses a harmless virus to teach the body to fight CMV, aiming to reduce infe…
Matched conditions: ACUTE LYMPHOBLASTIC LEUKEMIA IN REMISSION
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: ⭐️ VACCINE ⭐️
Last updated May 17, 2026 05:35 UTC
-
New radiation combo aims to boost transplant success in tough leukemias
Disease control TerminatedThis early-stage study tests a new way to prepare the body for a donor stem cell transplant in people with high-risk leukemia or myelodysplastic syndrome (MDS). It combines targeted radiation (TMLI) with two chemotherapy drugs to kill cancer cells and make room for healthy donor …
Matched conditions: ACUTE LYMPHOBLASTIC LEUKEMIA IN REMISSION
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
New transplant technique aims to cut deadly side effects in half-matched donor patients
Disease control OngoingThis study tests a new way to do stem cell transplants using cells from a half-matched family donor. By removing certain immune cells before transplant, researchers hope to lower the risk of graft-versus-host disease, a serious complication. The goal is to help patients with bloo…
Matched conditions: ACUTE LYMPHOBLASTIC LEUKEMIA IN REMISSION
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 11, 2026 20:49 UTC
-
Donor vaccine may shield transplant patients from dangerous virus
Prevention OngoingThis early-phase trial tests whether vaccinating stem cell donors against cytomegalovirus (CMV) can help protect the transplant recipient from CMV infection. About 34 people with blood cancers receiving a donor stem cell transplant will have their donors vaccinated before donatio…
Matched conditions: ACUTE LYMPHOBLASTIC LEUKEMIA IN REMISSION
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Prevention
Last updated May 06, 2026 16:13 UTC